FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Betrixaban (Bevyxxa) Capsules
Status: Discontinuation
»Therapeutic Categories: Hematology

Expand all

Portola Pharmaceuticals, Inc. (New 05/01/2020)

Company Contact Information:
866-777-5947

Presentation Posting Date Related Information
40 mg capsules (NDC 69853-0202-1) 05/01/2020
80 mg capsules (NDC 69853-0201-1) 05/01/2020

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English